213 related articles for article (PubMed ID: 5171066)
1. Levodopa in the treatment of Parkinsonism.
Cotzias GC
JAMA; 1971 Dec; 218(13):1903-8. PubMed ID: 5171066
[No Abstract] [Full Text] [Related]
2. Block of cerebral actions of L-dopa with methyl receptor substances.
Cotzias GC; Tang L; Ginos JZ; Nicholson AR; Papavasiliou PS
Nature; 1971 Jun; 231(5304):533-5. PubMed ID: 4934569
[No Abstract] [Full Text] [Related]
3. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Fehling C; Bell MA
N Engl J Med; 1972 Jan; 286(1):8-14. PubMed ID: 4550085
[No Abstract] [Full Text] [Related]
4. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
Dupont E; Hansen E; Melsens S; Parkenberg H; Holm P
Acta Neurol Scand Suppl; 1972; 51():115-7. PubMed ID: 4514334
[No Abstract] [Full Text] [Related]
5. Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
Calne DB; Reid JL; Vakil SD; Rao S; Petrie A; Pallis CA; Gawler J; Thomas PK; Hilson A
Br Med J; 1971 Sep; 3(5777):729-32. PubMed ID: 4938431
[TBL] [Abstract][Full Text] [Related]
6. Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future.
Hornykiewicz OD
Neurology; 1970 Dec; 20(12):1-5. PubMed ID: 5531292
[No Abstract] [Full Text] [Related]
7. [Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
Geissbühler F; Constantinidis J; Eisenring JJ; Krassoievitch M; Yanniotis G; Tissot R
Clin Chim Acta; 1971 Jun; 33(1):111-5. PubMed ID: 5097993
[No Abstract] [Full Text] [Related]
8. Dopa-decarboxylase inhibitors.
Lancet; 1973 May; 1(7810):979-80. PubMed ID: 4121597
[No Abstract] [Full Text] [Related]
9. Recent advances in the treatment of Parkinsonism with drugs.
Rinne UK
Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076
[No Abstract] [Full Text] [Related]
10. Levodopa and pressor amine sensitivity in parkinsonism.
Reid JL; Calne DB; George CF; Vakil SD
Clin Pharmacol Ther; 1972; 13(3):400-6. PubMed ID: 5026378
[No Abstract] [Full Text] [Related]
11. Ro 4-4602 and levodopa in the treatment of Parkinsonism.
Miller EM; Wiener L
Neurology; 1974 May; 24(5):482-6. PubMed ID: 4857107
[No Abstract] [Full Text] [Related]
12. The action of L(-)-dopa on baroreflexes in Parkinsonism.
Reid JL; Calne DB; George CF; Vakil SD
Clin Sci; 1972 Dec; 43(6):851-9. PubMed ID: 4646277
[No Abstract] [Full Text] [Related]
13. Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).
Holmsen R; Kvan L; Presthus J; Thoresen GB
Acta Neurol Scand Suppl; 1972; 51():121-2. PubMed ID: 4514336
[No Abstract] [Full Text] [Related]
14. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
Bianchine JR; Messiha FS; Hsu TH
Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
[No Abstract] [Full Text] [Related]
15. Treatment of Parkinsonism with L-dopa and decarboxylase inhibitors. An electrophysiological study.
Dietrichson P
Acta Neurol Scand Suppl; 1972; 51():111-3. PubMed ID: 4514333
[No Abstract] [Full Text] [Related]
16. Drug-induced changes in brain dopamine and their relation to parkinsonism.
Vogt M
Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
[No Abstract] [Full Text] [Related]
17. [Treatment of Parkinson's disease with L-dopa alone or combined with Ro 4-4602].
Barbeau A; Gillo-Joffroy L; Mars H; Arsenault A
Rev Can Biol; 1972; 31():Suppl:169-74. PubMed ID: 5052323
[No Abstract] [Full Text] [Related]
18. [Pathogenesis and treatment of manganese induced Parkinsonism].
Ryzhkova MN; Tarasova LA
Gig Tr Prof Zabol; 1975 Nov; (11):31-4. PubMed ID: 1205189
[No Abstract] [Full Text] [Related]
19. Similarities between neurologic effects of L-dopa and of apomorphine.
Cotzias GC; Papavasiliou PS; Fehling C; Kaufman B; Mena I
N Engl J Med; 1970 Jan; 282(1):31-3. PubMed ID: 4901383
[No Abstract] [Full Text] [Related]
20. Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.
Calne DB; Petrie A; Rao S; Reid JL; Vakil SD
Br J Pharmacol; 1972 Jan; 44(1):162-4. PubMed ID: 5015036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
